bepridil has been researched along with Substance Withdrawal Syndrome in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bepridil was well tolerated; most adverse reactions reported were mild and tolerable even at the 400-mg dose." | 6.67 | Comparative efficacy of bepridil versus placebo in angina pectoris: treatment and withdrawal studies. ( Shapiro, W, 1992) |
| "Bepridil was well tolerated; most adverse reactions reported were mild and tolerable even at the 400-mg dose." | 2.67 | Comparative efficacy of bepridil versus placebo in angina pectoris: treatment and withdrawal studies. ( Shapiro, W, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shapiro, W | 1 |
1 trial available for bepridil and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Comparative efficacy of bepridil versus placebo in angina pectoris: treatment and withdrawal studies.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Bepridil; Electrocardiography; Female; Humans; Male | 1992 |